Veteran fund manager makes bold move on Nvidia price target
Relax, people: Jensen Huang says there's nothing to worry about.
The Nvidia () CEO was looking to assure the U.S. government that it did not need to be concerned about the AI-chip superpower's technology being used by the Chinese military.
💵💰Don't miss the move: Subscribe to TheStreet's free daily newsletter 💰
"We don't have to worry about that because the Chinese military — no different to the American military — will not seek to build on top of each other's technology," Huang said in an interview with CNN. "They simply can't rely on it. It could, of course, be limited at any time."
The U.S. government, under both the Biden and Trump administrations, has implemented and progressively tightened restrictions on the sale of advanced AI chips to clients in China, citing national security concerns.
"If you just think about the number of supercomputers that are in China, built by amazing Chinese engineers that are already in operation, they don't need Nvidia's chips or American tech stacks in order to build their military," he said.
He said that export controls had been counterproductive to the ultimate goal of U.S. tech leadership, and that half the world's AI researchers are in China.
'We want the American tech stack to be the global standard. ... [In] order for us to do that, we have to be in search of all the AI developers in the world,' he said.
More Nvidia:
Analysts revamp forecast for Nvidia-backed AI stock
Nvidia stock could surge after surprising Taiwan Semi news
Nvidia CEO sends blunt 7-word message on quantum computing
Huang, who recently met with President Donald Trump and government and industry officials in Beijing, said Nvidia was filing applications to sell the Nvidia H20 GPU again.
The H20, a less powerful version of Nvidia's Hopper architecture H100 GPU, was created to meet U.S. export-control regulations while still enabling Nvidia to maintain a presence in the Chinese market.
This news was music to the ears of a lot of people in the investment community, including TheStreet Pro's Chris Versace.
"This should not only remove an overhanging question as to the future of Nvidia's China business but restore revenue that was written off as lost due to government restrictions," the lead portfolio manager of TheStreet Pro portfolio said in his July 15 column.
China generated $17 billion in revenue for Nvidia in 2024, roughly 13% of the company's total revenue, Versace said.
In response to the news, he lifted his Nvidia price target to $200 from $185 and reiterating his One rating.
"We are also thinking this is a positive step in smoothing U.S.-China trade conversations as the two countries work on a larger trade deal," he said.
President Trump is slated to announce $70 billion in artificial intelligence and energy investments, Versace said, which lends additional support for the price target increase.
In a related development, Versace said CoreWeave () , a key Nvidia customer, will commit as much as $6 billion for a Lancaster, Pa., 100-megawatt data center that could be expanded to 300 MW.
'We suspect there will be similar announcements from other companies as part of Trump's larger announcement, much the way we saw with the Stargate announcement in January,' he said, referring to the joint venture that plans to invest up to $500 billion in AI infrastructure.Versace said these announcements should affirm expectations for AI and data center demand in the coming quarters.
Connecting the dots, Versace said that would be "a positive demand driver for not only Nvidia and Marvell () shares, but also Eaton () , United Rentals () , and others."
Several investment firms issued research reports on Nvidia, including Bank of America Securities, which raised its price target to $220 from $180 and affirmed a buy rating on the shares.
The Department of Commerce allowing Nvidia and AMD () to resume artificial intelligence chip sales to China is an incremental positive for both companies, the firm said, according to The Fly.
B of A said the move expanded the addressable opportunity in AI for U.S. chipmakers by as much as 10% and improves the U.S.'s ability to dominate the global tech stack.
Piper Sandler maintained an overweight rating on Nvidia after the company said it expects to be granted licenses to resume H20 chip sales to China.
During the April quarter, the company posted $4.6 billion in sales for H20 and left an additional $2.5 billion on the table due to the ban, the firm said.
Piper said the estimated impact from the ban in the July quarter was around $8 billion in sales. The firm said that it suspected strong demand for these chips would have continued had the ban not been in place.Veteran fund manager makes bold move on Nvidia price target first appeared on TheStreet on Jul 16, 2025
This story was originally reported by TheStreet on Jul 16, 2025, where it first appeared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
2 Digital Healthcare Stocks Poised for a Breakout
Key Points Healthcare technology companies are transforming patient access and care delivery, creating massive addressable markets worth hundreds of billions of dollars. Digital-first platforms can scale rapidly without the infrastructure costs of traditional healthcare providers, enabling superior unit economics and profit margins. Regulatory challenges and competitive pressures create temporary volatility that often presents compelling entry points for long-term investors. 10 stocks we like better than Oscar Health › Wall Street loves to punish healthcare stocks for short-term stumbles while missing their revolutionary potential. The sector's reputation for regulatory complexity and unpredictable reimbursement changes has created a risk-averse investment environment that consistently undervalues companies building the future of American healthcare. This myopic view ignores a fundamental shift happening beneath the surface. Healthcare technology companies are dismantling decades-old barriers between patients and care, creating direct-pay models that bypass insurance bureaucracy entirely. While traditional healthcare stocks trade on Medicare Advantage enrollment growth and medical loss ratios (MLRs), these digital disruptors are building subscription-based businesses with software-like economics and massive total addressable markets. Two companies exemplify this transformation -- one sustaining strong profitability while navigating industry headwinds, the other riding explosive growth despite recent partnership drama. Both face meaningful risks that create entry opportunities for investors who understand the long-term digitization trends reshaping American healthcare. Oscar's profitable start meets cost pressures Oscar Health (NYSE: OSCR) built on its profitable start to 2025 with a strong first quarter, though emerging challenges in Q2 have tempered the momentum. The company reported $3 billion in revenue -- a 42% year-over-year increase -- and $275 million in net income, up from $177 million the previous year. This 55% profit growth underscores Oscar's scalable technology model, but investors should also consider recent indications of cost pressure and volatility. The company's MLR rose to 75.4% in the first quarter, still within industry norms but now expected to increase further, with full-year MLR guidance revised upward to 86% to 87% due to Q2 trends. This dramatic guidance revision signals significant cost headwinds that could pressure margins throughout the year. Oscar's differentiation lies in its digital-first infrastructure, built specifically for the digital age. Unlike legacy insurers, Oscar designed its operation around digital-first member engagement -- leveraging telemedicine, artificial intelligence (AI)-powered health assessments, and predictive analytics. This approach has enabled the company to serve approximately 2 million members while maintaining competitive administrative expense ratios. The +Oscar platform remains a compelling long-term opportunity, offering potential to license care navigation and engagement tools to third-party providers. While this strategy could create high-margin software revenue, monetization beyond internal use is still in early stages. Its success may prove essential as potential changes to Affordable Care Act subsidies introduce new uncertainties to the individual insurance market. Hims navigates explosive growth and regulatory crosswinds Hims & Hers Health (NYSE: HIMS) has delivered a dramatic performance through 2025, highlighting both the explosive potential and inherent risks of disruptive healthcare models. The stock reached an all-time high of $72.98 in February before encountering significant turbulence from regulatory scrutiny and partnership disputes. The company's underlying business growth remains exceptional despite headline challenges. First-quarter revenue surged 111% year over year to $586 million, while adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) nearly tripled to $91 million. More importantly, Hims & Hers expanded its subscriber base to 2.4 million customers -- a 38% increase -- with nearly 60% now using personalized treatment solutions that command premium pricing. However, the Novo Nordisk partnership termination in June caused a major decline in the stock. This dispute over Hims & Hers' continued sale of compounded weight-loss medications exposes the company's central vulnerability: regulatory dependence on legally gray areas of pharmaceutical compounding. Beyond weight management, Hims & Hers has systematically expanded into mental health, dermatology, and hormone replacement therapy -- with over 80% of 2024 revenue coming from non-GLP-1 sources. Each vertical leverages the company's direct-to-consumer infrastructure, creating cross-selling opportunities that increase customer lifetime value. Yet, this expansion strategy faces intensifying competition from well-funded digital health competitors and increasingly digital-savvy incumbents. Weighing the digital healthcare transformation The healthcare technology revolution creates compelling investment opportunities for investors who can tolerate regulatory uncertainty and competitive pressure in exchange for exposure to transformative business models. Oscar Health offers a mature, profitable approach to technology-enabled insurance with multiple avenues for margin expansion and revenue diversification. The company's established market position and strong balance sheet provide defensive characteristics, while its technology platform positions it to capture value from healthcare's digital transformation. Hims & Hers provides higher-risk, higher-reward exposure to the direct-pay healthcare revolution, where patients increasingly bypass insurance for convenient, affordable treatments. The company's ambitious 2030 targets of $6.5 billion in revenue and $1.3 billion in adjusted EBITDA reflect management's confidence in expanding beyond specialty medications into comprehensive primary care services. Should you buy stock in Oscar Health right now? Before you buy stock in Oscar Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Oscar Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $641,800!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,023,813!* Now, it's worth noting Stock Advisor's total average return is 1,034% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 George Budwell has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 2 Digital Healthcare Stocks Poised for a Breakout was originally published by The Motley Fool
Yahoo
35 minutes ago
- Yahoo
Prediction: Interactive Brokers Stock Will Soar Over the Next Decade
Key Points Interactive Brokers' recent top- and bottom-line growth helps justify the stock's increased valuation multiple. The company has incredible momentum in customer account growth. The online broker relies on proprietary automation to streamline operations and fuel growth. 10 stocks we like better than Interactive Brokers Group › While artificial intelligence stocks like Nvidia and Palantir may be the darlings of 2025's stock market headlines, another under-the-radar stock deserves similar attention. Even better, unlike Nvidia and Palantir, this stock still looks undervalued. Interestingly, this isn't even a tech stock. It's a financial company. I'm referring to the online stock brokerage Interactive Brokers (NASDAQ: IBKR). With its soaring revenue and profits, as well as its impressive customer account growth, this company's momentum looks poised to persist. Indeed, given the company's history of execution, its recent uptick in customer accounts, and its competitive advantage as a low-cost operator, it's highly likely that this stock will soar over the next decade. Stellar second-quarter results With shares of Interactive Brokers rising about 35% year to date going into the company's second-quarter earnings report last week, it's safe to say that expectations were elevated. Fortunately, the pureplay brokerage business, which prides itself on automation and low costs, delivered. Total revenue, driven primarily by a 27% year-over-year increase in commissions, rose more than 20% year over year. Earnings per share increased more than 24% year over year. Strong fundamentals like this importantly help support the growth stock's boosted valuation multiple. Shares now trade at a price-to-earnings multiple of 33, up from about 25 at the start of the year and from 20 at the lows during April's market sell-off. Momentum where it matters most To understand the bull case for Interactive Brokers, however, investors have to look beyond the company's reported revenue and earnings-per-share growth. Capturing its momentum is the online brokerage's strong customer metrics. Starting with the lifeblood of Interactive Brokers' business, its customer accounts increased an impressive 32% year over year during the quarter, rising to 3.87 million. The company's investments in automation are helping. "Our application processing is highly automated and continually becoming even more so, explained Interactive Brokers Director of Investor Relations Nancy Stuebe during the company's second-quarter earnings call, "allowing us to handle surges in new accounts efficiently, without adding significantly to our headcount or cost base." The company has added 528,000 customers in 2025 alone. Additionally, increased customer activity is helping. Total daily average revenue trades (DARTs) during the quarter rose 49% year over year to 3.55 million. Lately, activity has been aided by a volatile stock market. The period included April's sell-off and the subsequent V-shaped recovery in the stock market. "Volatility and uncertainty often spark increased market activity," Stuebe explained during the earnings call. "Combined with our strong net new account growth, this led to our client trading volumes expanding for stocks, options, and futures." Though it's worth noting that robust customer momentum isn't new for Interactive Brokers. The company consistently grows its customer accounts at strong, double-digit growth rates, regardless of the quarter's volatility. While recent customer account growth rates and DART growth are unlikely to be sustainable, investors should at least expect double-digit growth rates in the teens or better in both key customer metrics for the next few years and beyond. The bull case Overall, Interactive Broker's robust customer momentum, when combined with the company's highly automated operation, is a recipe for strong earnings growth for years to come. Of course, there are risks. If competing brokerages can replicate Interactive Brokers' automation, for instance, they could reverse their market share losses and ultimately slow Interactive Brokers' growth. Further, more than half of the company's revenue is currently generated from net interest income. If the Federal Reserve lowers interest rates, this line item will likely be hurt. Even with these risks, Interactive Brokers' strong customer momentum should easily offset declines in net interest income over the long haul. Furthermore, competition will likely struggle to replicate Interactive Brokers' secret recipe for automation -- a proprietary process the company has perfected over decades. While there's no guarantee that the stock will beat the market over the long haul, it seems likely. Given the stock's historical volatility, it will likely be a bumpy ride, but probably a worthwhile one. Do the experts think Interactive Brokers Group is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Interactive Brokers Group make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,034% vs. just 180% for the S&P — that is beating the market by 853.75%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $641,800!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,023,813!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Daniel Sparks and his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Interactive Brokers Group, Nvidia, and Palantir Technologies. The Motley Fool recommends the following options: long January 2027 $175 calls on Interactive Brokers Group and short January 2027 $185 calls on Interactive Brokers Group. The Motley Fool has a disclosure policy. Prediction: Interactive Brokers Stock Will Soar Over the Next Decade was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Dissenting FCC Commissioner: Paramount Chose 'Capitulation Over Courage' In Dealing With Trump
Though the Federal Communications Commission approved the Skydance-Paramount merger Thursday, one commissioner is speaking out against what she says has been an 'erosion of our First Amendment protections.' 'After months of cowardly capitulation to this Administration, Paramount finally got what it wanted. Unfortunately, it is the American public who will ultimately pay the price for its actions,' commissioner Anna M. Gomez said. More from The Hollywood Reporter Paramount Co-CEO Chris McCarthy Set to Exit After Skydance Merger Paramount-Skydance Merger Approved by FCC, Clearing Way for $8 Billion Deal Close 'South Park' Lives: Paramount Inks New Deal With Creators, Library Moving to Paramount+ Gomez notes that the transfer of Paramount's broadcast licenses to Skydance was approved by a vote of 2-1 at the FCC, which is led by Brendan Carr, and that she had dissented. She pointed to the 'unprecedented' moves taken by the FCC to help broker the deal, which she notes include the elimination of DEI programs and putting controls on newsroom decisions at CBS, including agreeing to appoint an ombudsman that will report directly to the president of CBS News and 'who will receive and evaluate any complaints of bias or other concerns.' On July 1, Paramount agreed to a $16 million deal to resolve a lawsuit filed by President Trump against 60 Minutes over an interview conducted with Kamala Harris. The settlement was largely seen as paving the way for the merger with Skydance. Trump has also said that he anticipates receiving at least $20 million in advertising, public service announcements or similar programming from Skydance as part of a settlement. 'In an unprecedented move, this once-independent FCC used its vast power to pressure Paramount to broker a private legal settlement and further erode press freedom. Once again, this agency is undermining legitimate efforts to combat discrimination and expand opportunity by overstepping its authority and intervening in employment matters reserved for other government entities with proper jurisdiction on these issues. Even more alarming, it is now imposing never-before-seen controls over newsroom decisions and editorial judgment, in direct violation of the First Amendment and the law,' Gomez wrote. 'After the FCC buried the outcome of backroom negotiations with other regulated entities, like Verizon and T-Mobile, I urged for us to bring the Paramount proceeding into the light. I've long believed the public has a right to know how Paramount's capitulation evidences an erosion of our First Amendment protections, and I'm pleased that FCC leadership ultimately agreed to my call for every Commissioner to vote on this transaction. Granting approval behind closed doors, under the cover of bureaucratic process, would have been an inappropriate way to shield this Administration's coordinated campaign to censor speech, control narratives, and silence dissent,' she continued. 'Despite this regrettable outcome, this Administration is not done with its assault on the First Amendment. In fact, it may only be beginning. The Paramount payout and this reckless approval have emboldened those who believe the government can—and should—abuse its power to extract financial and ideological concessions, demand favored treatment, and secure positive media coverage. It is a dark chapter in a long and growing record of abuse that threatens press freedom in this country. But such violations endure only when institutions choose capitulation over courage. It is time for companies, journalists, and citizens alike to stand up and speak out, because unchecked and unquestioned power has no rightful place in America,' Gomez wrote. Best of The Hollywood Reporter How the Warner Brothers Got Their Film Business Started Meet the World Builders: Hollywood's Top Physical Production Executives of 2023 Men in Blazers, Hollywood's Favorite Soccer Podcast, Aims for a Global Empire
